FDA APPROVES VALTREX

The FDA has approved a supplemental new drug application for Valtrex (valacyclovir HCI) manufactured by GlaxoSmithKline.

Related Videos
Related Content

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Study Finds Successful Switching Strategy for Patients with Psoriasis After Suboptimal Response

March 20th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

Advancements in Understanding the Skin's Microbiomes

March 20th 2023

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Study Finds Successful Switching Strategy for Patients with Psoriasis After Suboptimal Response

March 20th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

Advancements in Understanding the Skin's Microbiomes

March 20th 2023

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Study Finds Successful Switching Strategy for Patients with Psoriasis After Suboptimal Response

March 20th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

Advancements in Understanding the Skin's Microbiomes

March 20th 2023
© 2023 MJH Life Sciences

All rights reserved.